Daniel Kowalski

Clinscience

Clinscience is a global SMART CRO with hubs across five countries in Europe, the United States and India and has a satellite presence in additional 5 European countries. Since 2020, Clinscience offers full (end-to-end) CRO services from Protocol Development to Final Study Report. Over 150 Biotech Clients trust Our Brand and we expect many more in the near future. Our uncomplicated procedures and Data-driven approach harnessed with state-of-the-art technology allow us to be smart and agile in meeting our Clients' needs. Clinscience specializes in Oncology, Hemato-Oncology, Cardiovascular Diseases, and Neurology. It has managed more than 500 studies for 24+ therapeutic areas and recruited over 180,000+ patients across 4,900+ sites globally. The Company's procedures and Data-driven approach, harnessed with the Genius Suite™ technology, work together to give the Clients power and flexibility to address even the most unique needs. Clinscience is part of a publicly-traded parent company, Neuca Plc, an organization in the pharmaceutical wholesaling and healthcare industry that provides the structure to meet the needs of commercial and non-commercial studies. Visit www.clinscience.com for more information.